Spinal Anesthesia Can Be Safely Used in Severe Aortic Stenosis for Orthopedic Surgery with Specific Precautions
Spinal anesthesia is not contraindicated in patients with severe aortic stenosis undergoing orthopedic surgery, but requires ultra-low dose techniques, invasive hemodynamic monitoring, and immediate vasopressor availability to maintain coronary perfusion pressure.
Key Preoperative Requirements
Before proceeding with spinal anesthesia, ensure:
- Recent echocardiography (within 1 year) to quantify stenosis severity, calculate systolic function, and estimate right heart pressures 1
- Symptomatic status assessment is critical: symptomatic severe AS carries 2.7-fold higher risk of 30-day mortality and MI 1
- Consider valve replacement first if patient meets standard indications for intervention and surgery is elective 1, 2
For asymptomatic severe AS patients, elective low or intermediate-risk orthopedic surgery can proceed with appropriate monitoring 2
Spinal Anesthesia Technique Modifications
The traditional contraindication to spinal anesthesia in AS is outdated. Recent evidence demonstrates safety when using:
Ultra-Low Dose Protocol
- Use 6.25 mg or less of hyperbaric bupivacaine for unilateral spinal technique 3, 4
- Target sensory level of T6-T10 (T6 achieved in 44.4% of cases) 3
- Consider continuous spinal anesthesia for incremental dosing control in highest-risk patients 4
Hemodynamic Rationale
The sympathetic blockade from ultra-low dose spinal is more gradual and controllable than the myocardial depression from general anesthesia induction agents. A 2024 systematic review of 3,228 patients with AS receiving neuraxial anesthesia found no intraoperative cardiovascular collapse or mortality, with hypotension requiring vasopressors in only 9.9% of noncardiac cases 5.
Mandatory Intraoperative Monitoring
Invasive arterial line placement is essential before induction 1. The fixed stroke volume in AS means cardiac output depends entirely on heart rate and preload—you cannot tolerate even brief hypotension.
Hemodynamic Goals
- Maintain mean arterial pressure 75-85 mmHg (documented stable range in successful cases) 4
- Avoid tachycardia (target HR 60-70 bpm): decreased diastolic filling time reduces coronary perfusion 1
- Preserve sinus rhythm: atrial kick contributes 30-40% of ventricular filling in AS
- Maintain preload: avoid hypovolemia but prevent fluid overload
Vasopressor Strategy
- Have phenylephrine infusion prepared before block 6
- Pure alpha-agonists are preferred (maintain SVR without tachycardia)
- Treat hypotension immediately—do not wait for symptoms
Comparison to General Anesthesia
A 2022 propensity-matched study of 163 AS patients undergoing lower extremity arthroplasty found no difference in 90-day mortality (GA 0% vs SA 1%), serious complications, or hospital length of stay between spinal and general anesthesia 7. This challenges the historical preference for general anesthesia in AS.
High-Risk Features Requiring Extra Caution
Predictors of 30-day mortality and MI in AS patients include 1:
- Symptomatic severe AS (OR 2.7)
- Coexisting moderate-severe mitral regurgitation (OR 9.8)
- Pre-existing coronary artery disease (OR 2.7)
- High-risk surgery type (OR 7.3)
If multiple risk factors present, consider postoperative ICU monitoring regardless of anesthetic technique 1.
Common Pitfalls to Avoid
- Do not use standard spinal doses: Traditional 12-15 mg bupivacaine causes excessive sympathectomy
- Do not rely on non-invasive blood pressure: Beat-to-beat arterial monitoring is mandatory
- Do not allow gradual hypotension: Coronary perfusion occurs in diastole—even modest MAP drops are dangerous
- Do not assume asymptomatic = low risk: 30-day mortality in asymptomatic severe AS is still 2.1% vs 1.0% in matched controls 1
When to Abort Spinal Approach
Proceed to general anesthesia if:
- Unable to establish invasive monitoring
- Patient develops symptomatic hypotension during positioning
- Concurrent severe mitral regurgitation with decompensated heart failure
- Emergency surgery without time for optimization
The 2024 systematic review concluded that neuraxial anesthesia may not be contraindicated in carefully selected AS patients 5, and the 2017 review found no clinical evidence supporting adverse effects when carefully managed 8.